Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatment.

Stemkens R, Litjens CHC, Dian S, Ganiem AR, Yunivita V, van Crevel R, Te Brake LHM, Ruslami R, Aarnoutse RE.

Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30163-3. doi: 10.1016/j.ijantimicag.2019.06.010. [Epub ahead of print]

PMID:
31202922
2.

Immune cell characteristics and cytokine responses in adult HIV-negative tuberculous meningitis: an observational cohort study.

van Laarhoven A, Dian S, van Dorp S, Purnama F, Koeken VACM, Diandini E, Utami F, Livia R, Apriani L, Ardiansyah E, Ter Horst R, Netea MG, Achmad TH, Hill PC, Ruslami R, Alisjahbana B, Ussher JE, Indrati A, Verrall A, Ganiem AR, van Crevel R.

Sci Rep. 2019 Jan 29;9(1):884. doi: 10.1038/s41598-018-36696-3.

3.

Barriers to diagnosis and management of CNS infections in Indonesia.

Imran D, Satiti S, Sugianto P, Estiasari R, Maharani K, Pangeran D, Andini PW, Munir B, Mawuntu AHP, Susilawathi NM, Ritarwan K, Hartanto OS, Frida M, Ganiem AR, Gunawan D, Dian S, Sudewi AAR, van Crevel R.

Neurology. 2019 Jan 8;92(2):104-106. doi: 10.1212/WNL.0000000000006732. No abstract available.

PMID:
30617169
4.

Presentation, etiology, and outcome of brain infections in an Indonesian hospital: A cohort study.

Imran D, Estiasari R, Maharani K, Sucipto, Lestari DC, Yunus RE, Yunihastuti E, Karyadi TH, Oei D, Timan IS, Wulandari D, Wahyuningsih R, Adawiyah R, Kurniawan A, Mulyadi R, Karuniawati A, Jaya UA, Safari D, van Laarhoven A, Alisjahbana B, Dian S, Chaidir L, Ganiem AR, Lastri DN, Aye Myint KS, van Crevel R.

Neurol Clin Pract. 2018 Oct;8(5):379-388. doi: 10.1212/CPJ.0000000000000517.

PMID:
30564491
5.

Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis.

Dian S, Yunivita V, Ganiem AR, Pramaesya T, Chaidir L, Wahyudi K, Achmad TH, Colbers A, Te Brake L, van Crevel R, Ruslami R, Aarnoutse R.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01014-18. doi: 10.1128/AAC.01014-18. Print 2018 Dec.

6.

Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl-Neelsen stain, GeneXpert, and culture of cerebrospinal fluid.

Heemskerk AD, Donovan J, Thu DDA, Marais S, Chaidir L, Dung VTM, Centner CM, Ha VTN, Annisa J, Dian S, Bovijn L, Mai NTH, Phu NH, Chau NVV, Ganiem AR, Van CT, Geskus RB, Thuong NTT, Ruslami R, Meintjes G, van Crevel R, Wilkinson RJ, Thwaites GE.

J Infect. 2018 Dec;77(6):509-515. doi: 10.1016/j.jinf.2018.09.003. Epub 2018 Sep 12.

7.

Predicting Mortality of Tuberculous Meningitis.

Dian S, Rahmadi R, van Laarhoven A, Ganiem AR, van Crevel R.

Clin Infect Dis. 2018 Nov 28;67(12):1954-1955. doi: 10.1093/cid/ciy445. No abstract available.

PMID:
29860408
8.

Neuromarker Levels Also Predict Mortality in Adult Tuberculous Meningitis.

van Laarhoven A, Koeken VACM, Dian S, Ganiem AR, van Crevel R.

Clin Infect Dis. 2018 Aug 1;67(4):642-643. doi: 10.1093/cid/ciy126. No abstract available.

PMID:
29617975
9.

Microbiological diagnosis of adult tuberculous meningitis in a ten-year cohort in Indonesia.

Chaidir L, Annisa J, Dian S, Parwati I, Alisjahbana A, Purnama F, van der Zanden A, Ganiem AR, van Crevel R.

Diagn Microbiol Infect Dis. 2018 May;91(1):42-46. doi: 10.1016/j.diagmicrobio.2018.01.004. Epub 2018 Jan 9.

PMID:
29444749
10.

Large-scale genomic analysis shows association between homoplastic genetic variation in Mycobacterium tuberculosis genes and meningeal or pulmonary tuberculosis.

Ruesen C, Chaidir L, van Laarhoven A, Dian S, Ganiem AR, Nebenzahl-Guimaraes H, Huynen MA, Alisjahbana B, Dutilh BE, van Crevel R.

BMC Genomics. 2018 Feb 5;19(1):122. doi: 10.1186/s12864-018-4498-z.

11.

Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.

van Laarhoven A, Dian S, Aguirre-Gamboa R, Avila-Pacheco J, Ricaño-Ponce I, Ruesen C, Annisa J, Koeken VACM, Chaidir L, Li Y, Achmad TH, Joosten LAB, Notebaart RA, Ruslami R, Netea MG, Verbeek MM, Alisjahbana B, Kumar V, Clish CB, Ganiem AR, van Crevel R.

Lancet Infect Dis. 2018 May;18(5):526-535. doi: 10.1016/S1473-3099(18)30053-7. Epub 2018 Feb 3.

PMID:
29395996
12.

Reply to Neeradi et al and Dhawan and Sankhyan.

van Laarhoven A, Dian S, Ganiem AR, van Crevel R.

J Infect Dis. 2017 Aug 1;216(3):395-396. doi: 10.1093/infdis/jix319. No abstract available.

PMID:
28859434
13.

Fuzzy dynamic output feedback H control for continuous-time T-S fuzzy systems under imperfect premise matching.

Zhao T, Dian S.

ISA Trans. 2017 Sep;70:248-259. doi: 10.1016/j.isatra.2017.05.001. Epub 2017 May 17.

PMID:
28528137
14.

Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.

van Laarhoven A, Dian S, Ruesen C, Hayati E, Damen MSMA, Annisa J, Chaidir L, Ruslami R, Achmad TH, Netea MG, Alisjahbana B, Rizal Ganiem A, van Crevel R.

J Infect Dis. 2017 Apr 1;215(7):1029-1039. doi: 10.1093/infdis/jix051.

PMID:
28419315
15.

Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients.

Yunivita V, Dian S, Ganiem AR, Hayati E, Hanggono Achmad T, Purnama Dewi A, Teulen M, Meijerhof-Jager P, van Crevel R, Aarnoutse R, Ruslami R.

Int J Antimicrob Agents. 2016 Oct;48(4):415-21. doi: 10.1016/j.ijantimicag.2016.06.016. Epub 2016 Jul 26.

PMID:
27526979
16.

Proactive Alleviation Procedure to Handle Black Hole Attack and Its Version.

Babu MR, Dian SM, Chelladurai S, Palaniappan M.

ScientificWorldJournal. 2015;2015:715820. doi: 10.1155/2015/715820. Epub 2015 Oct 1.

17.

Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis.

Te Brake L, Dian S, Ganiem AR, Ruesen C, Burger D, Donders R, Ruslami R, van Crevel R, Aarnoutse R.

Int J Antimicrob Agents. 2015 May;45(5):496-503. doi: 10.1016/j.ijantimicag.2014.12.027. Epub 2015 Feb 7.

PMID:
25703312
18.

Pharmacokinetics and efficiency of brain targeting of ginsenosides Rg1 and Rb1 given as Nao-Qing microemulsion.

Li T, Shu YJ, Cheng JY, Liang RC, Dian SN, Lv XX, Yang MQ, Huang SL, Chen G, Yang F.

Drug Dev Ind Pharm. 2015 Feb;41(2):224-31. doi: 10.3109/03639045.2013.858734. Epub 2013 Nov 18.

PMID:
24237326
19.

[Technical study of vinpocetine micelles prepared by thin-film hydration method].

Huang ZJ, Li T, Guo XJ, Wang YT, Yang MQ, Huang SL, Yang F, Dian SN.

Zhong Yao Cai. 2012 Nov;35(11):1850-4. Chinese.

PMID:
23627101
20.

Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from Indonesia.

Ganiem AR, Dian S, Indriati A, Chaidir L, Wisaksana R, Sturm P, Melchers W, van der Ven A, Parwati I, van Crevel R.

PLoS Negl Trop Dis. 2013;7(1):e1994. doi: 10.1371/journal.pntd.0001994. Epub 2013 Jan 10.

21.

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.

Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, Borm G, Aarnoutse RE, van Crevel R.

Lancet Infect Dis. 2013 Jan;13(1):27-35. doi: 10.1016/S1473-3099(12)70264-5. Epub 2012 Oct 25.

PMID:
23103177

Supplemental Content

Support Center